Skip to content
Home/Companies/Biotech/MetGen
ME

MetGen

Biotech·Finland·Active·9yr hold

MetGen is a industry / biotech company, headquartered in Finland.

Entry
2017
Hold
9yr
Status
Active
Est. EV
–

Who owns MetGen?

MetGen is currently owned by Sofinnova Partners through Sofinnova Industrial Biotech (2018 vintage), since 2017.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Industrial Biotech · 2018 · VC

Key facts

HQFinland
SectorIndustry / Biotech

More from Sofinnova Industrial Biotech

Other portfolio companies in the same fund.

Arzeda
Active
BiotechUS· 2022
IB WORKS I
Exited 2024
SoftwareFrance· 2022
Prometheus Materials
Active
BiotechUS· 2022
Novameat
Active
BiotechSpain· 2021
Qorium
Active
BiotechNetherlands· 2021
Verley (formerly Bon Vivant)
Active
BiotechFrance· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings